Lysosomal membrane protein disorders

I-Cell Disease - Address Unknown

• Inheritance: Autosomal Recessive.
• Defect: Failure of Golgi to phosphorylate mannose residues on lysosomal proteins (failure of N-acetylglucosaminyl-1-phosphotransferase).
• Pathophysiology: Lysosomal enzymes are secreted extracellularly instead of being delivered to the lysosome. This leads to the accumulation of cellular debris (inclusions) inside the cell.

• Clinical: Presents in infancy with coarse facial features, clouded corneas, restricted joint movement, and skeletal abnormalities.

⭐ Diagnosis: High levels of lysosomal enzymes in the plasma, while intracellular levels are low.

📌 Mnemonic: I-C-E-L-L → Inclusion Cells, Enzymes Loose in Lymph.

Transport Defects - Cellular Gridlock

• I-Cell Disease (Mucolipidosis II)

  • Pathophysiology: Autosomal recessive defect in N-acetylglucosaminyl-1-phosphotransferase. This prevents the phosphorylation of mannose residues to mannose-6-phosphate (M6P) on lysosomal hydrolases.
  • Result: Enzymes are secreted extracellularly instead of being delivered to lysosomes. Substrates accumulate within lysosomes, forming characteristic inclusion cells.
  • Features: Presents in infancy with coarse facial features, gingival hyperplasia, clouded corneas, skeletal abnormalities (dysostosis multiplex), and severe psychomotor delay.
  • 📌 Mnemonic: I-CELL = Inclusions in Cytoplasm, Enzymes Lost from Lysosome.

• Cystinosis

  • Pathophysiology: Defect in the lysosomal cystine transporter, cystinosin (CTNS gene).
  • Result: Accumulation and crystallization of cystine within lysosomes.
  • Features: Leads to renal tubular Fanconi syndrome, photophobia (corneal cystine crystals), and progressive renal failure.

⭐ In I-cell disease, the hydrolase enzymes themselves are functional, but are secreted into the plasma. This leads to high plasma levels of lysosomal enzymes, a key diagnostic finding.

Niemann-Pick Type C - Cholesterol Jam

• Pathophysiology: Autosomal recessive disorder from mutations in NPC1 (95%) or NPC2 genes, disrupting cholesterol transport out of lysosomes.
• Mechanism: Leads to intracellular accumulation of unesterified cholesterol and glycosphingolipids, creating a cellular "traffic jam."
• Clinical Triad:
  • Neurologic: Progressive ataxia, dystonia, and cognitive decline. Vertical supranuclear gaze palsy (VSGP) is a hallmark sign.
  • Visceral: Hepatosplenomegaly, often presenting with prolonged neonatal jaundice.
  • Psychiatric: Early-onset psychosis or behavioral issues in adult forms.
• Diagnosis:
  • Biochemical: Filipin stain on cultured fibroblasts shows characteristic perinuclear cholesterol accumulation.
  • Biomarkers: Elevated plasma oxysterols (e.g., cholestane-3β, 5α, 6β-triol).
  • Genetic: Definitive diagnosis via NPC1/NPC2 gene sequencing.

⭐ Exam Favorite: Vertical supranuclear gaze palsy (difficulty with voluntary up-and-down eye movements) is the most specific early neurological sign.

High‑Yield Points - ⚡ Biggest Takeaways

• I-cell disease results from a defective N-acetylglucosaminyl-1-phosphotransferase, leading to failure of mannose-6-phosphate tagging.
• Lysosomal enzymes are subsequently secreted extracellularly, causing high plasma levels.
• Key features include coarse facial features, dysostosis multiplex, and clouded corneas.
• Cystinosis is a defect in the CTNS gene (cystinosin), causing cystine crystal accumulation.
• Salla disease and ISSD involve defects in the sialic acid transporter, sialin.